251 related articles for article (PubMed ID: 29529391)
1. Scribble influences cyst formation in autosomal-dominant polycystic kidney disease by regulating Hippo signaling pathway.
Xu D; Lv J; He L; Fu L; Hu R; Cao Y; Mei C
FASEB J; 2018 Aug; 32(8):4394-4407. PubMed ID: 29529391
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of the Hippo pathway by adherens junctions and apical-basal cell polarity modules.
Yang CC; Graves HK; Moya IM; Tao C; Hamaratoglu F; Gladden AB; Halder G
Proc Natl Acad Sci U S A; 2015 Feb; 112(6):1785-90. PubMed ID: 25624491
[TBL] [Abstract][Full Text] [Related]
3. Altered Hippo signalling in polycystic kidney disease.
Happé H; van der Wal AM; Leonhard WN; Kunnen SJ; Breuning MH; de Heer E; Peters DJ
J Pathol; 2011 May; 224(1):133-42. PubMed ID: 21381034
[TBL] [Abstract][Full Text] [Related]
4. Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice.
Park EY; Sung YH; Yang MH; Noh JY; Park SY; Lee TY; Yook YJ; Yoo KH; Roh KJ; Kim I; Hwang YH; Oh GT; Seong JK; Ahn C; Lee HW; Park JH
J Biol Chem; 2009 Mar; 284(11):7214-22. PubMed ID: 19098310
[TBL] [Abstract][Full Text] [Related]
5. Hippo signaling-a central player in cystic kidney disease?
Müller RU; Schermer B
Pediatr Nephrol; 2020 Jul; 35(7):1143-1152. PubMed ID: 31297585
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
Ishimoto Y; Inagi R; Yoshihara D; Kugita M; Nagao S; Shimizu A; Takeda N; Wake M; Honda K; Zhou J; Nangaku M
Mol Cell Biol; 2017 Dec; 37(24):. PubMed ID: 28993480
[TBL] [Abstract][Full Text] [Related]
7. Scribble participates in Hippo signaling and is required for normal zebrafish pronephros development.
Skouloudaki K; Puetz M; Simons M; Courbard JR; Boehlke C; Hartleben B; Engel C; Moeller MJ; Englert C; Bollig F; Schäfer T; Ramachandran H; Mlodzik M; Huber TB; Kuehn EW; Kim E; Kramer-Zucker A; Walz G
Proc Natl Acad Sci U S A; 2009 May; 106(21):8579-84. PubMed ID: 19439659
[TBL] [Abstract][Full Text] [Related]
8. Metformin Inhibits Cyst Formation in a Zebrafish Model of Polycystin-2 Deficiency.
Chang MY; Ma TL; Hung CC; Tian YC; Chen YC; Yang CW; Cheng YC
Sci Rep; 2017 Aug; 7(1):7161. PubMed ID: 28769124
[TBL] [Abstract][Full Text] [Related]
9. Zebrafish Model as a Screen to Prevent Cyst Inflation in Autosomal Dominant Polycystic Kidney Disease.
Oliveira I; Jacinto R; Pestana S; Nolasco F; Calado J; Lopes SS; Roxo-Rosa M
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445719
[TBL] [Abstract][Full Text] [Related]
10. Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.
Spirli C; Mariotti V; Villani A; Fabris L; Fiorotto R; Strazzabosco M
J Hepatol; 2017 Mar; 66(3):571-580. PubMed ID: 27826057
[TBL] [Abstract][Full Text] [Related]
11. SNX9 Inhibits Cell Proliferation and Cyst Development in Autosomal Dominant Polycystic Kidney Disease via Activation of the Hippo-YAP Signaling Pathway.
Shen AW; Fu LL; Lin L; Sun B; Song DX; Wang WT; Wang YH; Yin PR; Yu SQ
Front Cell Dev Biol; 2020; 8():811. PubMed ID: 32974348
[TBL] [Abstract][Full Text] [Related]
12. Yes-associated protein (Yap) is necessary for ciliogenesis and morphogenesis during pronephros development in zebrafish (Danio Rerio).
He L; Xu W; Jing Y; Wu M; Song S; Cao Y; Mei C
Int J Biol Sci; 2015; 11(8):935-47. PubMed ID: 26157348
[TBL] [Abstract][Full Text] [Related]
13. The Cyst Epithelium in Polycystic Kidney Disease Patients Displays Normal Apical-Basolateral Cell Polarity.
Sandegaard SL; Riishede A; Birn H; Damkier HH; Praetorius J
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339183
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1/cyclin axis.
Li A; Fan S; Xu Y; Meng J; Shen X; Mao J; Zhang L; Zhang X; Moeckel G; Wu D; Wu G; Liang C
J Cell Mol Med; 2017 Aug; 21(8):1619-1635. PubMed ID: 28244683
[TBL] [Abstract][Full Text] [Related]
15. Autophagy activators suppress cystogenesis in an autosomal dominant polycystic kidney disease model.
Zhu P; Sieben CJ; Xu X; Harris PC; Lin X
Hum Mol Genet; 2017 Jan; 26(1):158-172. PubMed ID: 28007903
[TBL] [Abstract][Full Text] [Related]
16. Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD).
Nikonova AS; Deneka AY; Kiseleva AA; Korobeynikov V; Gaponova A; Serebriiskii IG; Kopp MC; Hensley HH; Seeger-Nukpezah TN; Somlo S; Proia DA; Golemis EA
FASEB J; 2018 May; 32(5):2735-2746. PubMed ID: 29401581
[TBL] [Abstract][Full Text] [Related]
17. Metformin suppresses proliferation and invasion of drug-resistant breast cancer cells by activation of the Hippo pathway.
Liu J; Li J; Chen H; Wang R; Li P; Miao Y; Liu P
J Cell Mol Med; 2020 May; 24(10):5786-5796. PubMed ID: 32281270
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation, protein kinases and ADPKD.
Li X
Biochim Biophys Acta; 2011 Oct; 1812(10):1219-24. PubMed ID: 21392577
[TBL] [Abstract][Full Text] [Related]
19. Activation of P-TEFb by cAMP-PKA signaling in autosomal dominant polycystic kidney disease.
Sun Y; Liu Z; Cao X; Lu Y; Mi Z; He C; Liu J; Zheng Z; Li MJ; Li T; Xu D; Wu M; Cao Y; Li Y; Yang B; Mei C; Zhang L; Chen Y
Sci Adv; 2019 Jun; 5(6):eaaw3593. PubMed ID: 31183407
[TBL] [Abstract][Full Text] [Related]
20. CXCR2 agonists in ADPKD liver cyst fluids promote cell proliferation.
Amura CR; Brodsky KS; Gitomer B; McFann K; Lazennec G; Nichols MT; Jani A; Schrier RW; Doctor RB
Am J Physiol Cell Physiol; 2008 Mar; 294(3):C786-96. PubMed ID: 18199703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
